Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome

BJU International

Volumn 108, Issue 2 B, 2011, Pages

  Mir, Maria Carmen ^a   Trilla, Enrique ^a   De Torres, Ines Maria ^a   Panizo, Angel ^b   Zlotta, Alexander R ^c   Van Rhijn, Bas ^c   Morote, Juan ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

cromosome Xp 11.2; immunohistochemistry; renal carcinoma; translocation carcinoma

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; CYTOKERATIN 8; MELAN A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E3; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; BACKACHE; BONE METASTASIS; CANCER GRADING; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME XP; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISTANT METASTASIS; GENE FUSION; GENE OVEREXPRESSION; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; TUMOR NECROSIS; TUMOR VOLUME; VEIN THROMBOSIS;

ADULT; AGED; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 79960078989     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09818.x     Document Type: Article

References (18)

1. Argani P, Ladanyi M,. Translocation carcinomas of the kidney. Clin Lab Med 2005; 25: 363-78 (Pubitemid 40545824)
2. Argani P, Hawkins A, Griffin CA, et al,. A distinctive pediatric renal neoplasm characterized by epitheliod morphology, basement membrane production, focal HMB45 immunoreactivity and t(6;11) (p21.1;q12) chromosome translocation. Am J Pathol 2001; 158: 2089-96 (Pubitemid 32545194)
3. Bogan JS, Hendon N, McKee AE, et al,. Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking. Nature 2003; 425: 727-33 (Pubitemid 37314316)
4. Argani P, Lal P, Hutchinson B, et al,. Aberrant nuclear immunoreactivity for the TFE3 in neoplasmas with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003; 27: 750-61 (Pubitemid 36617511)
5. Argani P, Antonescu CR, Illei PB, et al,. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sacoma. A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159: 179-92 (Pubitemid 33704203)
6. Komai Y, Fujiwara M, Fujii Y, et al,. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res 2009; 15: 1170-6
7. Estrada C, Sutra A, Eaton S, et al,. Renal cell carcinoma: Children's Hospital Boston experience. Urology 2005; 66: 1296-300 (Pubitemid 41797308)
8. Selle B, Furtwangler R, Graf N, Kaatsch P, Bruder E, Leuschner I,. Population-based study of renal cell carcinoma in children in Germany, 1980-2005. Cancer 2006; 107: 2906-14
9. Indolfi P, Terenziani M, Casle F, et al,. Renal cell carcinoma in children: a clinicopathologic study. J Clin Oncol 2003; 21: 530-5 (Pubitemid 46606484)
10. Geller JI, Dome JS,. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 2004; 101: 1575-83 (Pubitemid 39318904)
11. Geller JI, Argani P, Adeniran A, et al,. Translocation renal cell carcnomas: lack of negative impact due to lymph node spread. Cancer 2008; 112: 1607-16 (Pubitemid 351441175)
12. Argani P, Olgac S, Tickoo SK, et al,. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathological and genetic spectrum. Am J Surg Pathol 2007; 31: 1149-60 (Pubitemid 47207116)
13. Wu A, Kunju LP, Cheng L, Shah RB,. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation- associated and unusual clear cell subtypes. Histopathology 2008; 53: 533-44
14. Rais-Bahrami S, Drabick J, de Marzo A, et al,. Xp11 translocation renall cell carcinoma: delayed but massive and letal metastases of a chemotherapy-associated secondary malignancy. Urology 2007; 70: 178. e3-6
15. Huang F, Zwerdling T, Stern L, et al,. Renal cell carcinoma asa secondary malignancy after treatment of acute promielocitic leukemia. J Pediatr Hematol Oncol 2001; 23: 609-11 (Pubitemid 34073868)
16. Argani P, Lae M, Ballard E, et al,. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 2006; 24: 1529-34 (Pubitemid 46638774)
17. Ramphal R, Pappo A, Zielenska M, et al. Pediatric renal cell carcinoma: clinical, pathologic and molecular abnormalities associated with the members of the MiT transcription factor family. Am J Clin Pathol 2006; 126: 349-64 (Pubitemid 44338787)
18. Tsuda M, Davis IJ, Argani P, et al,. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res 2007; 67: 919-29